{"id":4491,"date":"2021-09-02T08:37:28","date_gmt":"2021-09-02T06:37:28","guid":{"rendered":"http:\/\/www.infokuryr.cz\/n\/?p=4491"},"modified":"2021-09-02T08:37:28","modified_gmt":"2021-09-02T06:37:28","slug":"evropska-komise-varuje-pred-preockovanim-proti-covid-19","status":"publish","type":"post","link":"https:\/\/www.infokuryr.cz\/n\/2021\/09\/02\/evropska-komise-varuje-pred-preockovanim-proti-covid-19\/","title":{"rendered":"Evropsk\u00e1 komise varuje p\u0159ed p\u0159eo\u010dkov\u00e1n\u00edm proti COVID-19"},"content":{"rendered":"
<\/div>\n

Evropsk\u00e1 komise se domn\u00edv\u00e1, \u017ee nen\u00ed k dispozici dostatek informac\u00ed o mo\u017en\u00fdch rizic\u00edch spojen\u00fdch s pod\u00e1n\u00edm t\u0159et\u00ed d\u00e1vky pacient\u016fm.<\/span><\/p>\n

Evropsk\u00e1 komise (ES)\u00a0v prohl\u00e1\u0161en\u00ed pro\u00a0<\/span>tiskovou agenturu Reuters<\/span><\/a><\/strong>\u00a0varovala zem\u011b EU p\u0159ed jednostrann\u00fdm zaveden\u00edm dodate\u010dn\u00fdch posilovac\u00edch o\u010dkov\u00e1n\u00ed pro experiment\u00e1ln\u00ed \u201evakc\u00edny\u201c proti COVID.<\/span><\/p>\n

EK zast\u00e1v\u00e1 n\u00e1zor, \u017ee nen\u00ed dostatek informac\u00ed o mo\u017en\u00fdch rizic\u00edch spojen\u00fdch s pod\u00e1n\u00edm t\u0159et\u00ed d\u00e1vky pacient\u016fm, jak ji\u017e mnoho evropsk\u00fdch zem\u00ed pl\u00e1nuje.<\/span><\/p>\n

V mnoha zem\u00edch je nab\u00edzeno dodate\u010dn\u00e9 posilovac\u00ed o\u010dkov\u00e1n\u00ed jako mo\u017enost v\u00fdrazn\u011b zv\u00fd\u0161it imunitu o\u010dkovan\u00fdch, a to i proti nov\u00fdm variant\u00e1m, pot\u00e9, co bylo jasn\u011b prok\u00e1z\u00e1no, \u017ee takzvan\u00ed \u201epln\u011b o\u010dkovan\u00ed\u201c lid\u00e9 nejsou v \u017e\u00e1dn\u00e9m p\u0159\u00edpad\u011b zcela chr\u00e1n\u011bni p\u0159ed infekc\u00ed, a to plat\u00ed i pro \u0161\u00ed\u0159en\u00ed zodpov\u011bdn\u00e9ho koronaviru za COVID -19.<\/span><\/p>\n

Evropsk\u00e1 agentura pro l\u00e9\u010div\u00e9 p\u0159\u00edpravky v sou\u010dasn\u00e9 dob\u011b nen\u00ed ochotna schv\u00e1lit \u201et\u0159et\u00ed o\u010dkov\u00e1n\u00ed\u201c, co\u017e znamen\u00e1, \u017ee zem\u011b, kter\u00e9 doporu\u010duj\u00ed dodate\u010dn\u00e9 o\u010dkov\u00e1n\u00ed pro takzvan\u00e9 \u201epln\u011b o\u010dkovan\u00e9\u201c osoby, budou muset n\u00e9st d\u016fsledky, pokud nastanou probl\u00e9my.<\/span><\/p>\n

Agentura Reuters citovala Evropskou komisi, v\u00fdkonn\u00fd org\u00e1n EU, kter\u00fd \u0159ekl:\u00a0<\/span>„Posilovac\u00ed vakcinace v sou\u010dasn\u00e9 dob\u011b nejsou sou\u010d\u00e1st\u00ed registrace vakc\u00edn proti COVID-19 a agentura EMA je zat\u00edm kv\u016fli nedostatku \u00fadaj\u016f v\u011bdecky neposuzovala.“<\/span><\/em><\/p>\n

V prohl\u00e1\u0161en\u00ed Komise je uvedeno, \u017ee \u201eodpov\u011bdnost za rozhodnut\u00ed zahrnout posilovac\u00ed o\u010dkov\u00e1n\u00ed do o\u010dkovac\u00edch kampan\u00ed z\u016fst\u00e1v\u00e1 na \u010dlensk\u00fdch st\u00e1tech (…), pokud posilovac\u00ed o\u010dkov\u00e1n\u00ed nen\u00ed sou\u010d\u00e1st\u00ed registrace, odpov\u011bdnost spole\u010dnost\u00ed se zm\u011bn\u00ed\u201c.<\/span><\/p>\n

Jin\u00fdmi slovy, ani EU, ani Pfizer, Moderna, Johnson & Johnson a AstraZeneca, \u010dty\u0159i spole\u010dnosti, kter\u00e9 z\u00edskaly v\u00fdlu\u010dn\u00e9 rozhodnut\u00ed o registraci pro sv\u00e9 \u201evakc\u00edny\u201c v EU, nejsou pova\u017eov\u00e1ny za zodpov\u011bdn\u00e9 za \u017e\u00e1dn\u00e9 ne\u017e\u00e1douc\u00ed \u00fa\u010dinky, kter\u00e9 to m\u016f\u017ee zp\u016fsobit by norm\u00e1ln\u011b umo\u017enilo ob\u011btem vym\u00e1hat n\u00e1hradu \u0161kody.<\/span><\/p>\n

V sou\u010dasn\u00e9 dob\u011b nen\u00ed zcela jasn\u00e9, kdo nese jakoukoliv odpov\u011bdnost za ne\u017e\u00e1douc\u00ed \u00fa\u010dinky experiment\u00e1ln\u00edch injekc\u00ed proteinov\u00fdch vakc\u00edn. Na\u0159\u00edzen\u00ed Evropsk\u00e9 unie plat\u00ed, pokud jsou ne\u017e\u00e1douc\u00ed \u00fa\u010dinky klasifikov\u00e1ny jako \u201eneo\u010dek\u00e1van\u00e9\u201c a souvisej\u00ed bu\u010f s obecn\u00fdmi vlastnostmi v\u00fdrobku, nebo se zp\u016fsobem jeho v\u00fdroby.\u00a0O\u010dek\u00e1v\u00e1 se, \u017ee \u010dlensk\u00e9 st\u00e1ty budou kompenzaci regulovat podle pravidel EU, zat\u00edmco z\u00fa\u010dastn\u011bn\u00e9 laborato\u0159e sjednaj\u00ed s EU zvl\u00e1\u0161tn\u00ed ustanoven\u00ed, kter\u00e1 z v\u011bt\u0161\u00ed \u010d\u00e1sti z\u016fst\u00e1vaj\u00ed d\u016fv\u011brn\u00e1.<\/span><\/p>\n

Evropsk\u00e1 komise nastoluje ot\u00e1zku \u201eneo\u010dek\u00e1van\u00fdch\u201c vedlej\u0161\u00edch \u00fa\u010dink\u016f, u nich\u017e bylo prok\u00e1z\u00e1no, \u017ee jsou zp\u016fsobeny pod\u00e1n\u00edm dal\u0161\u00edho posilovac\u00edho o\u010dkov\u00e1n\u00ed.\u00a0Takov\u00e9 posilovac\u00ed o\u010dkov\u00e1n\u00ed ji\u017e doporu\u010duj\u00ed Francie, Rakousko, Belgie, Ma\u010farsko, Lichten\u0161tejnsko, Litva, Lucembursko, \u010cesk\u00e1 republika<\/strong> a Slovinsko, aby-jak se \u0159\u00edk\u00e1-p\u016fsobilo proti sl\u00e1bnouc\u00ed \u201eochran\u011b\u201c, proto\u017ee varianta SARS-CoV-2-Delta nad\u00e1le nahrazuje koronavirus proti kter\u00e9mu byly vyvinuty schv\u00e1len\u00e9 \u201evakc\u00edny\u201c.<\/span><\/p>\n

N\u011bmecko a dal\u0161\u00edch 14 zem\u00ed EU tak\u00e9 zva\u017euje nab\u00eddnout – ne -li povinnou – t\u0159et\u00ed d\u00e1vku sv\u00fdm \u201ezraniteln\u00fdm\u201c ob\u010dan\u016fm, proto\u017ee je st\u00e1le v\u00edce pravd\u011bpodobn\u00e9, \u017ee se zm\u011bn\u00ed definice \u201e\u00fapln\u00e9ho o\u010dkov\u00e1n\u00ed\u201c ve vztahu ke zdravotn\u00edm pas\u016fm, kter\u00e9 jsou v n\u011bkolika zem\u00edch EU vy\u017eadov\u00e1ny pro mnoho ka\u017edodenn\u00edch \u010dinnost\u00ed.<\/span><\/p>\n

Komise informuje ty, kte\u0159\u00ed si p\u0159ej\u00ed podat t\u0159et\u00ed d\u00e1vku – jak Francie pl\u00e1nuje u\u010dinit se svou star\u0161\u00ed populac\u00ed a s komorbidn\u00edmi pacienty od 13. z\u00e1\u0159\u00ed -, \u017ee vl\u00e1dy samy pravd\u011bpodobn\u011b ponesou hlavn\u00ed t\u00edhu\u00a0 soudn\u00edch spor\u016f souvisej\u00edc\u00edch s tak z\u00e1va\u017en\u00fdmi vedlej\u0161\u00edmi \u00fa\u010dinky.<\/span><\/p>\n

Jedna zem\u011b mimo EU, Izrael, ji\u017e za\u010dala zav\u00e1d\u011bt dal\u0161\u00ed posilovac\u00ed o\u010dkov\u00e1n\u00ed;\u00a0kampa\u0148 \u201et\u0159et\u00ed d\u00e1vky\u201c za\u010dala p\u0159ed v\u00edce ne\u017e m\u011bs\u00edcem pro osoby star\u0161\u00ed 60 let a nyn\u00ed byla roz\u0161\u00ed\u0159ena na v\u0161echny ob\u010dany od 12 let.\u00a0To znamen\u00e1, \u017ee na mlad\u00e9 lidi v Izraeli je nyn\u00ed vyv\u00edjen tlak, aby podstoupili t\u0159et\u00ed o\u010dkov\u00e1n\u00ed, p\u0159ed \u010d\u00edm\u017e varuje i instituce kritick\u00e1 pro o\u010dkov\u00e1n\u00ed, jako je Evropsk\u00e1 komise.<\/span><\/p>\n

Po\u010det \u00famrt\u00ed v Izraeli p\u0159ipisovan\u00fdch COVID je na denn\u00edm po\u0159\u00e1dku a od 29. \u010dervence neust\u00e1le roste a \u201ep\u0159\u00edpad\u016f\u201c st\u00e1le p\u0159ib\u00fdv\u00e1 a dosahuje \u00farovn\u00ed, kter\u00e9 nebyly zaznamen\u00e1ny od za\u010d\u00e1tku krize COVID. \u00damrtnost je ni\u017e\u0161\u00ed, ne\u017e b\u00fdvala, ofici\u00e1ln\u011b p\u0159ipisov\u00e1na roz\u0161\u00ed\u0159en\u00e9mu o\u010dkov\u00e1n\u00ed, ale v nedalek\u00e9m Jord\u00e1nsku, kde je proo\u010dkovanost dvakr\u00e1t ni\u017e\u0161\u00ed, z\u016fst\u00e1vaj\u00ed \u201ep\u0159\u00edpady\u201c i \u00famrt\u00ed extr\u00e9mn\u011b n\u00edzk\u00e9.\u00a0V Izraeli se dokonce uva\u017euje o nucen\u00ed populace se op\u011bt uzav\u0159\u00edt.<\/span><\/strong><\/p>\n

Zat\u00edmco mainstreamov\u00e1 m\u00e9dia prosazuj\u00ed dodate\u010dn\u00e9 p\u0159eo\u010dkov\u00e1n\u00ed, znovu populaci sd\u011bluj\u00edc\u00ed, \u017ee toto je jedin\u00fd zp\u016fsob, jak obej\u00edt omezen\u00ed COVID a \u201eporazit\u201c virus, alternativn\u00ed webov\u00e9 str\u00e1nky dlouhodob\u011b varuj\u00ed populaci p\u0159ed specifick\u00fdmi riziky spojen\u00fdmi s t\u0159et\u00ed d\u00e1vkou o\u010dkov\u00e1n\u00ed mRNA (Pfizer a Moderna) nebo adenovirov\u00e9 o\u010dkov\u00e1n\u00ed (AstraZeneca a Johnson & Johnson).<\/span><\/p>\n

Kritici tvrd\u00ed, \u017ee \u201e\u017eiv\u00fd\u201c \u0161pi\u010dat\u00fd protein, kter\u00fd je z\u00e1kladem \u010dty\u0159 o\u010dkov\u00e1n\u00ed schv\u00e1len\u00fdch EU, je ve sv\u00e9 podstat\u011b toxick\u00fd a je zodpov\u011bdn\u00fd za onemocn\u011bn\u00ed, kter\u00e9 postihuje lidi s v\u00e1\u017en\u00fdm onemocn\u011bn\u00edm COVID, a \u017ee opakovan\u00e1 produkce tohoto proteinu, p\u0159i n\u00ed\u017e jsou lidsk\u00e9 bu\u0148ky podvedeny k jeho produkci, zvy\u0161uje riziko v\u00e1\u017en\u00fdch komplikac\u00ed.<\/span><\/p>\n

Jean-Marc Sabatier, \u0159editel v\u00fdzkumu francouzsk\u00e9ho n\u00e1rodn\u00edho v\u00fdzkumn\u00e9ho centra CNRS a l\u00e9ka\u0159 bun\u011b\u010dn\u00e9 biologie a mikrobiologie, se domn\u00edv\u00e1, \u017ee v\u00fdrobci by m\u011bli zajistit, aby se \u0161pi\u010dat\u00e9 proteiny injektovan\u00e9 sou\u010dasn\u00fdmi \u201evakc\u00ednami\u201c nep\u0159ipojily k receptor\u016fm v lidsk\u00e9m t\u011ble aby se zabr\u00e1nilo mo\u017enosti o\u010dkovan\u00fdch u nich vyvinout onemocn\u011bn\u00ed podobn\u00e9 COVID, jako jsou vedlej\u0161\u00ed \u00fa\u010dinky spojen\u00e9 s krevn\u00edmi sra\u017eeninami.<\/span><\/p>\n

Je proti t\u0159et\u00edmu a (pro\u010d ne?) \u010ctvrt\u00e9mu o\u010dkov\u00e1n\u00ed (proto\u017ee nen\u00ed dosa\u017eena \u00fapln\u00e1 imunita), proto\u017ee sou\u010dasn\u00fd postup se dv\u011bma (nebo jednou, u spole\u010dnosti Johnson & Johnson) vakc\u00ednami ji\u017e vedl k p\u0159\u00edpad\u016fm vylep\u0161en\u00ed z\u00e1visl\u00fdch na protil\u00e1tk\u00e1ch (ADE) ), ve kter\u00e9m je o\u010dkovan\u00fd vystaven infekci prost\u0159ednictv\u00edm internalizace komplex\u016f vir\u016f a protil\u00e1tek.<\/span><\/p>\n

Sabatier varuje, \u017ee s dodate\u010dn\u00fdm p\u0159eo\u010dkov\u00e1n\u00edm by t\u0159et\u00ed a \u010dtvrt\u00e9 o\u010dkov\u00e1n\u00ed zv\u00fd\u0161ilo riziko vzniku \u201e\u00falevy\u201c protil\u00e1tek, kter\u00e9 by pomohly viru se mno\u017eit.<\/span><\/p>\n

Dal\u0161\u00ed respektovan\u00ed v\u011bdci a zdravotn\u00edci opakovan\u011b varovali p\u0159ed t\u0159et\u00ed nebo \u010dtvrtou injekc\u00ed.\u00a0Pat\u0159\u00ed mezi n\u011b Michael Yeadon a Sucharit Bhakdi, kte\u0159\u00ed ji\u017e v \u00fanoru 2021 v debat\u011b varovali o \u0161pi\u010dkov\u00fdch proteinov\u00fdch injekc\u00edch, \u017ee posilovac\u00ed o\u010dkov\u00e1n\u00ed zp\u016fsob\u00ed komplikace krevn\u00edch sra\u017eenin a tyto se zv\u00fd\u0161\u00ed.<\/span><\/p>\n

V sou\u010dasn\u00e9 dob\u011b ji\u017e sledov\u00e1n\u00ed vedlej\u0161\u00edch \u00fa\u010dink\u016f prok\u00e1zalo, \u017ee s pou\u017e\u00edv\u00e1n\u00edm p\u0159edchoz\u00edch \u201evakc\u00edn\u201c proti COVID-19 je spojena \u0159ada tromb\u00f3z a srde\u010dn\u00edch probl\u00e9m\u016f.<\/span><\/p>\n

Jen ve Francii k 19. srpnu zaregistrovala N\u00e1rodn\u00ed agentura pro bezpe\u010dnost l\u00e9\u010div 78 639 ne\u017e\u00e1douc\u00edch \u00fa\u010dink\u016f u \u010dty\u0159 schv\u00e1len\u00fdch \u201evakc\u00edn\u201c proti COVID-19, z nich\u017e \u010dtvrtina byla klasifikov\u00e1na jako \u201ez\u00e1va\u017en\u00e1\u201c.\u00a0Nedostate\u010dn\u00e9 hl\u00e1\u0161en\u00ed komplikac\u00ed je zn\u00e1m\u00fdm probl\u00e9mem.\u00a0Sociolog a v\u00fdzkumn\u00edk CNRS Laurent Mucchielli ned\u00e1vno publikoval studii, kter\u00e1 zjistila, \u017ee celkov\u00e1 \u00famrtnost spojen\u00e1 s \u201eo\u010dkovac\u00edmi l\u00e1tkami\u201c proti COVID ve Francii dos\u00e1hla 3,7 \u00famrt\u00ed na 100 000 o\u010dkovan\u00fdch lid\u00ed, nebo kolem 1 000 \u00famrt\u00ed do \u010dervence 2021.<\/span><\/p>\n

\"\"<\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Evropsk\u00e1 komise se domn\u00edv\u00e1, \u017ee nen\u00ed k dispozici dostatek informac\u00ed o mo\u017en\u00fdch rizic\u00edch spojen\u00fdch s…<\/p>\n","protected":false},"author":2,"featured_media":1468,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[7],"tags":[223,213,523,21],"_links":{"self":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts\/4491"}],"collection":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/comments?post=4491"}],"version-history":[{"count":0,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts\/4491\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/media\/1468"}],"wp:attachment":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/media?parent=4491"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/categories?post=4491"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/tags?post=4491"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}